PHARMACOKINETICS OF CARBOPLATINUM IN SERUM AND INTRAPERITONEAL-FLUID AFTER INTRAPERITONEAL ADMINISTRATION

被引:4
|
作者
CZEJKA, M
JAGER, W
SCHULLER, J
TEHERANI, D
机构
[1] KRANKENANSTALT RUDOLFSTIFTUNG WIEN,ONKOL ABT,A-1030 VIENNA,AUSTRIA
[2] OSTERREICH FORSCHUNGSZENT SEIBERSDORF GMBH,INST BIOL,A-2444 SEIBERSDORF,AUSTRIA
关键词
D O I
10.1002/ardp.19913240310
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The concentration-profile of the antineoplastic agent carboplatinum in serum and intraperitoneal-fluid (IPF) of six female patients was studied. Pharmaco-kinetical analysis showed a rapid distribution-phase between both compartments within the first 4 h after administration (t1/2 serum = 4.4 h, t1/2 IPF = 3.3 h). Elimination half-life of carboplatinum of 20.3 h from the blood-vessel-system was significantly higher than from the intraperitoneal-compartment (t1/2 = 10.6 h). The relative bioavailability (calculated as AUC-values) was at least 6 times higher for the IPF than for serum within the first 48 h. 98% of measured amount were eliminated from both compartments within this time. The desired high IPF-levels support this route of administration.
引用
收藏
页码:183 / 184
页数:2
相关论文
共 50 条
  • [1] PHARMACOKINETICS OF CARBOPLATIN AFTER INTRAPERITONEAL ADMINISTRATION
    ELFERINK, F
    VANDERVIJGH, WJF
    KLEIN, I
    HUININK, WWT
    DUBBELMAN, R
    MCVIE, JG
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1988, 21 (01) : 57 - 60
  • [2] CLINICAL PHARMACOKINETICS OF MITOXANTRONE AFTER INTRAPERITONEAL ADMINISTRATION
    NAGEL, JD
    VAROSSIEAU, FJ
    DUBBELMAN, R
    HUININK, WWT
    MCVIE, JG
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1992, 29 (06) : 480 - 484
  • [3] PHARMACOKINETICS OF GLUTATHIONE ON INTRAPERITONEAL ADMINISTRATION
    BELKINA, ZV
    KOBZEVA, NA
    UZBEKOVA, DG
    FARMAKOLOGIYA I TOKSIKOLOGIYA, 1981, 44 (05): : 622 - 624
  • [4] EPIRUBICIN PHARMACOKINETICS AFTER INTRAHEPATIC ARTERIAL AND INTRAPERITONEAL ADMINISTRATION
    STROCCHI, E
    CAMAGGI, CM
    ROSSI, AP
    ANGELELLI, B
    COMPARSI, R
    FRANCHINI, A
    DELPRETE, P
    COLA, B
    PANNUTI, F
    DRUGS UNDER EXPERIMENTAL AND CLINICAL RESEARCH, 1985, 11 (04) : 295 - 301
  • [5] CYTARABINE PHARMACOKINETICS FOLLOWING INTRAPERITONEAL ADMINISTRATION
    KING, ME
    PFEIFLE, CE
    MARKMAN, M
    HOWELL, SB
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1983, 33 (02) : 222 - 222
  • [6] The Pharmacokinetics of Ropivacaine After Intraperitoneal Administration: Instillation Versus Nebulization
    Betton, Delphine
    Greib, Nicolas
    Schlotterbeck, Herve
    Joshi, Girish P.
    Ubeaud-Sequier, Genevieve
    Diemunsch, Pierre
    ANESTHESIA AND ANALGESIA, 2010, 111 (05): : 1140 - 1145
  • [7] Pharmacokinetics of bupivacaine after intraperitoneal administration to cats undergoing ovariohysterectomy
    Benito, Javier
    Monteiro, Beatriz P.
    Beaudry, Francis
    Lavoie, Anne-Marie
    Lascelles, B. Duncan X.
    Steagall, Paulo V.
    AMERICAN JOURNAL OF VETERINARY RESEARCH, 2016, 77 (06) : 641 - 645
  • [8] PHARMACOKINETICS OF THE HYPOXIC RADIOSENSITIZERS MISONIDAZOLE AND DEMETHYLMISONIDAZOLE AFTER INTRAPERITONEAL ADMINISTRATION IN HUMANS
    GIANNI, L
    JENKINS, JF
    GREENE, RF
    LICHTER, AS
    MYERS, CE
    COLLINS, JM
    CANCER RESEARCH, 1983, 43 (02) : 913 - 916
  • [9] Population pharmacokinetics of oxaliplatin after intraperitoneal administration with hyperthermia in Wistar rats
    Mas-Fuster, M. I.
    Ramon-Lopez, A.
    Lacueva, F. J.
    Arroyo, A.
    Mas-Serrano, P.
    Nalda-Molina, R.
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2018, 119 : 22 - 30